Q1 Revenue Hits $198M for U.S. Physical Therapy, 2026 EBITDA Guidance Reaffirmed
summarizeSummary
U.S. Physical Therapy reported first-quarter revenue of $198 million, representing a 7.9% year-over-year increase, and reaffirmed its full-year 2026 adjusted EBITDA guidance in the range of $102 million to $106 million. This news provides specific financial details, including the exact revenue figure and a clear outlook, which were not fully detailed in the earlier Q1 reports from May 6th and May 8th. The reaffirmation of guidance is a significant signal of management's confidence in its operational trajectory, especially as the stock trades near its 52-week low. Traders will likely consider this a stabilizing factor, providing clarity on the company's expected performance. Investors should monitor the company's execution against this guidance and any further operational developments.
At the time of this announcement, USPH was trading at $59.42 on NYSE in the Trade & Services sector, with a market capitalization of approximately $898.6M. The 52-week trading range was $58.19 to $93.50. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.